Roivant Sciences Ltd (ROIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -290,606 | -397,907 | -753,651 | -439,950 | -273,911 |
| Depreciation Amortization | 600 | 3,348 | 2,710 | 2,019 | 1,098 |
| Accounts payable and accrued liabilities | 7,109 | 3,418 | -12,737 | -8,749 | -11,745 |
| Other Working Capital | -32,695 | -621,796 | -20,719 | -30,091 | -37,166 |
| Other Operating Activity | 45,088 | 262,588 | 197,866 | 86,724 | 117,341 |
| Operating Cash Flow | $-270,504 | $-750,349 | $-586,531 | $-390,047 | $-204,383 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 281,679 | -3,673,555 | -1,047,124 | -953,411 | -1,801,681 |
| PPE Investments | -419 | -8,209 | -6,948 | -11,883 | -4,035 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | 720,000 |
| Sale Of Investment | N/A | 3,006,367 | 200,766 | N/A | N/A |
| Other Investing Activity | 0 | -6,936 | -2,518 | 0 | 0 |
| Investing Cash Flow | $281,260 | $-682,333 | $-855,824 | $-965,294 | $-1,085,716 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 76,654 | 463,110 | 411,925 | 99,125 | 30,057 |
| Common Stock Repurchased | -206,729 | -319,503 | -208,293 | -208,293 | -208,293 |
| Other Financing Activity | -51,435 | -9,371 | -619 | -16,013 | -9,532 |
| Financing Cash Flow | $-181,510 | $134,236 | $203,013 | $-125,181 | $-187,768 |
| Exchange Rate Effect | 315 | 3,767 | 2,451 | 2,021 | 815 |
| Beginning Cash Position | 1,430,982 | 2,725,661 | 2,725,661 | 2,725,661 | 2,725,661 |
| End Cash Position | 1,260,543 | 1,430,982 | 1,488,770 | 1,247,160 | 1,248,609 |
| Net Cash Flow | $-170,439 | $-1,294,679 | $-1,236,891 | $-1,478,501 | $-1,477,052 |
| Free Cash Flow | |||||
| Operating Cash Flow | -270,504 | -750,349 | -586,531 | -390,047 | -204,383 |
| Capital Expenditure | -419 | -8,209 | -6,948 | -11,883 | -4,035 |
| Free Cash Flow | -270,923 | -758,558 | -593,479 | -401,930 | -208,418 |